Advertisement covers CROI 2013

More on HIV and Aging: One Study Whose Impact Will Last Well Beyond CROI 2013

March 14, 2013

It's expected that half of the U.S. HIV-infected population will be over the age of 50 soon. For this reason, there has been growing interest in the spectrum of non-AIDS medical complications in HIV-infected people. Key questions focus on whether the rates of these complications are higher, or occur at a younger age, in HIV-infected persons.

Data from the massive and well-characterized Veterans Aging Cohort Study (VACS), comparing 68,558 HIV-uninfected to 31,454 HIV-infected people, were presented. HIV-infected individuals had greater rates of myocardial infarction, end-stage renal disease and HIV-associated cancer. However, there were no differences in the rate of other cancers, nor were there differences in the mean age at heart, kidney or non-AIDS cancer diagnosis.

These data argue against the development of myocardial infarction, end-stage renal disease or non-AIDS cancers at younger ages in HIV-infected individuals.

Which other studies presented at CROI 2013 will have lasting impact long after memories of the conference itself have faded? Read more of Dr. Llibre and Dr. Young's top picks.

Copyright © 2013 Remedy Health Media, LLC. All rights reserved.


No comments have been made.

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read's Comment Policy.)

Your Name:

Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.


The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.